Wall Street analysts jumping on Lilly train
For more than two years, Eli Lilly and Co. has pushed the message that the worst days are over and a brighter future is just around the corner. Now, finally, Wall Street is starting to believe.
Health Care Businesses
Articles
Americans getting fed up over high drug prices
A new poll shows that a growing number of people feel drug prices are unreasonable, and they favor a variety of government actions to keep prices down.
Analysis: Diabetes drug price war likely to claim more casualties
Pharma giant Novo Nordisk announced Thursday that it is cutting 1,000 jobs after slashing forecasts for 2016, citing lower prices for diabetes drugs. Novo and competitors such as Indianapolis-based Eli Lilly will likely have to keep tightening their belts as prices and profit margins fall, experts say.
Health advocates gain favor to help employees navigate health care complexities
Employers began hiring health advocates in earnest nationwide about four years ago, fueled by implementation of the Affordable Care Act and growing public awareness that provider rates and quality can differ greatly.
The Interview Issue: Billie Dragoo
Founder of RepuCare, a 200-employee medical staffing company, Billie Dragoo has become one of central Indiana’s most fervent advocates for women. She’s a past CEO and board chairwoman of the National Association of Women Business Owners and co-founder of the Indiana Conference for Women.
The Interview Issue: Betty Cockrum
Betty Cockrum’s job is not one for the faint of heart. As president and CEO of Planned Parenthood of Indiana and Kentucky, she is often in the spotlight, fighting to maintain reproductive and abortion services across the state. But despite the high-profile role, Cockrum says she’s actually an introvert.
Super-sized laundry co-op serves 55 hospitals, 700 clinics
Just two years after United Hospital Services pushed into Kokomo by merging with North Central Indiana Linen Service, the co-op is planning its next move—this time into northwest Indiana.
Humble medical office buildings selling for kingly sums
The latest local example of the sizzling market is the three-story Community Health Pavilion, which sold last week for $286 a square foot—far more than the per-square-foot price in two recent office complex transactions.
Under fire, maker of EpiPen launching cheaper, generic version
Mylan will start selling a cheaper version of the emergency allergy treatment after absorbing waves of criticism over a growing list price that made it unaffordable for many patients.
The most unsexy sex report you’ll read today
A 214-page court ruling on a patent dispute involving testosterone treatments is a window into the very clinical world of sex drugs.
Lilly, partner lose court fight over testosterone treatment
Eli Lilly and Co. and its partner cannot stop competitors from selling generic versions of testosterone treatment Axiron, a federal judge in Indianapolis has ruled.
St. Vincent plans to build ‘micro-hospitals’ throughout area
St. Vincent will expand its footprint in central Indiana by opening eight small hospitals where patients can get treated for medical conditions that aren’t life-threatening. The first four locations were announced Monday.
Lilly drug for Alzheimer’s gets fast-tracked by FDA
Named AZD3293, the drug belongs to a novel class of drugs that block production of amyloid, a protein that causes plaque to build up in the brain of Alzheimer’s patients.
Carmel doctor found not guilty of charges from 2014 raid
Judge Steve Nation found that Dr. Larry Ley had met all of the standards for prescribing medicine for drug addiction after a bench trial in Hamilton County Superior Court.
Cialis users sue Lilly, claiming drug has ties to skin cancer
Seven men who took Cialis pills to treat erectile dysfunction sued Indianapolis drugmaker Eli Lilly and Co. this week, claiming they later suffered from skin cancer that was related to the medicine.
AIT meltdown derails huge Marian gift
Five years after pledging an astounding $48 million to help Marian University build a medical school, an Indianapolis businessman has paid only about one-fifth of that amount.
Incoming Lilly CEO pick to focus globally
Dave Ricks will begin guiding the company during a period of relative calm compared with the trying times John Lechleiter navigated during his eight years at the helm.
‘Smooth transition’ predicted as Lilly turns to experienced exec
Over the last eight years, Eli Lilly relied on a three-decade company veteran to steer it through declining sales and a struggling product pipeline. Now, it’ll rely on another long-time executive for its next chapter.
Lilly beats analyst expectations, lays out bright outlook for rest of decade
CEO John Lechleiter said the company's strong R&D pipeline has put it on track to report average annual revenue growth of at least 5 percent through the remainder of the decade.
Lilly stock rises after FDA panel backs new Jardiance label
A hot-selling drug for diabetes sold by Eli Lilly and Co. and a co-partner just got another potential boost, as a government panel narrowly recommended that the companies should be allowed to claim that the drug cuts the risk of cardiovascular death.